FindMyKOL
Clinical trialNCT00876382CompletedObservational

Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma

SponsorSCRI Development Innovations, LLCEnrollment47Renal Cell Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A retrospective medical record abstraction study of at least 200 advanced renal cell carcinoma patients treated in the following settings: * Patients with advanced renal cell carcinoma treated with Sorafenib (Nexavar) as second-line therapy after Sunitinib (Sutent) or Bevacizumab (Avastin) for first-line therapy (about 100 patients) * Patients with advanced renal cell carcinoma treated with Sorafenib (Nexavar) as first-line therapy followed by Sunitinib (Sutent) as second-line therapy (about 100 patients)
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Northeast Arkansas Clinic

    Jonesboro, Arkansas, United States

  • Gulfcoast Oncology Associates

    St. Petersburg, Florida, United States

  • Medical Oncology Associates of Augusta

    Augusta, Georgia, United States

  • Consultants in Blood Disorders and Cancer

    Louisville, Kentucky, United States

  • Jackson Oncology Associates

    Jackson, Mississippi, United States

  • St. Louis Cancer Care

    Chesterfield, Missouri, United States

  • Oncology Hematology Care

    Cincinnati, Ohio, United States

  • Tennessee Oncology, Pllc

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2009
Primary completion
28 Feb 2011
Completion
31 Aug 2011
Last update posted
14 Nov 2013
Registered enrollment
47
Registry id
NCT00876382
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.